-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Evofem Biosciences, Inc. quarterly/annual Revenues history and growth rate from Q3 2019 to Q3 2023.
- Evofem Biosciences, Inc. Revenues for the quarter ending October 31, 2023 was $100M, a 1470% increase year-over-year.
- Evofem Biosciences, Inc. annual Revenues for 2022 was $16.8M, a 104% increase from 2021.
- Evofem Biosciences, Inc. annual Revenues for 2021 was $8.24M, a 1748% increase from 2020.
- Evofem Biosciences, Inc. annual Revenues for 2020 was $446K.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)